Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations

Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations

Ling Lin1 ,* Xiaomai Wu1 ,* Shuangquan Yan,1 Yefei Zhu,1 Zhengqing Yan,2 Dongqing Lv,1 Hongfei Ge3 1Department of Respiratory Medicine, Taizhou Hospital of Wenzhou Medical University, Taizhou, People’s Republic of China; 2The Medical Department, 3D Medicines Inc., Shanghai, People&rsqu...

Full description

Bibliographic Details
Main Authors: Lin L, Wu X, Yan S, Zhu Y, Yan Z, Lv D, Ge H
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:OncoTargets and Therapy
Subjects:
afatinib
lung adenocarcinoma
egfr exon 20 insertions
next generation sequencing
Online Access:https://www.dovepress.com/response-to-afatinib-in-a-patient-with-nsclc-harboring-novel-egfr-exon-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/response-to-afatinib-in-a-patient-with-nsclc-harboring-novel-egfr-exon-peer-reviewed-article-OTT

Similar Items